[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=acdbbd661b6065b590e0fb696972e2ed801bfd26371595b643481cda23032003",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754411760,
      "headline": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors",
      "id": 136236198,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=acdbbd661b6065b590e0fb696972e2ed801bfd26371595b643481cda23032003"
    }
  },
  {
    "ts": null,
    "headline": "HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down",
    "summary": "Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber growth.",
    "url": "https://finnhub.io/api/news?id=d512bced954bb01e6c53adde9e1f3e068508bb46aa898510b4f886087239df75",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754408400,
      "headline": "HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down",
      "id": 136215007,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber growth.",
      "url": "https://finnhub.io/api/news?id=d512bced954bb01e6c53adde9e1f3e068508bb46aa898510b4f886087239df75"
    }
  },
  {
    "ts": null,
    "headline": "INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts",
    "summary": "Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.",
    "url": "https://finnhub.io/api/news?id=34d03456f63688f4375d707a39f62bd71c5d54650ccaaccdbc1276ea205f8284",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754408280,
      "headline": "INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts",
      "id": 136215008,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.",
      "url": "https://finnhub.io/api/news?id=34d03456f63688f4375d707a39f62bd71c5d54650ccaaccdbc1276ea205f8284"
    }
  },
  {
    "ts": null,
    "headline": "Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top",
    "summary": "HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.",
    "url": "https://finnhub.io/api/news?id=39657e6b013d99836649a356c872d8f4c8e06da49694853c310459cfd6cdf6ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754399100,
      "headline": "Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top",
      "id": 136215009,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.",
      "url": "https://finnhub.io/api/news?id=39657e6b013d99836649a356c872d8f4c8e06da49694853c310459cfd6cdf6ed"
    }
  },
  {
    "ts": null,
    "headline": "CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in Austin",
    "summary": "AUSTIN, Texas, August 05, 2025--CMCT signs 30,821 sf lease with Boston Scientific at 228,000 sf Penn Field Creative Office Campus in Austin bringing property to 93% leased",
    "url": "https://finnhub.io/api/news?id=8cdf87ac207a059c6caebe8cd3a16bb6c89d8cb50ae5e2e003482f2037477601",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754395200,
      "headline": "CMCT Announces 30,821-Square-Foot Lease to Boston Scientific Corporation at Penn Field, a 228,000-Square-Foot Creative Office Campus in Austin",
      "id": 136212405,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "AUSTIN, Texas, August 05, 2025--CMCT signs 30,821 sf lease with Boston Scientific at 228,000 sf Penn Field Creative Office Campus in Austin bringing property to 93% leased",
      "url": "https://finnhub.io/api/news?id=8cdf87ac207a059c6caebe8cd3a16bb6c89d8cb50ae5e2e003482f2037477601"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Mid Cap Growth Managed Account Q2 2025 Commentary",
    "summary": "Janus Henderson Mid Cap Growth Managed Account returned 7.71% (gross) and the Russell MidcapÂ® Growth Index returned 18.20%. Read more here.",
    "url": "https://finnhub.io/api/news?id=53a215f5d212f0825ba87a74a738d55b73e32a7f0aa26343898b8578984e5d72",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754389140,
      "headline": "Janus Henderson Mid Cap Growth Managed Account Q2 2025 Commentary",
      "id": 136213285,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1305098938/image_1305098938.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson Mid Cap Growth Managed Account returned 7.71% (gross) and the Russell MidcapÂ® Growth Index returned 18.20%. Read more here.",
      "url": "https://finnhub.io/api/news?id=53a215f5d212f0825ba87a74a738d55b73e32a7f0aa26343898b8578984e5d72"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary",
    "summary": "Janus Henderson Global Life Sciences Diversified ADR Managed Account returned -3.68% (gross) and the MSCI World Health Care Index returned -3.96%. Read more here.",
    "url": "https://finnhub.io/api/news?id=43278605299a51388bd3eed265ac982c872aaf1763e0851ee415ae42adb8f45e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754374920,
      "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q2 2025 Commentary",
      "id": 136207822,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/171573445/image_171573445.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson Global Life Sciences Diversified ADR Managed Account returned -3.68% (gross) and the MSCI World Health Care Index returned -3.96%. Read more here.",
      "url": "https://finnhub.io/api/news?id=43278605299a51388bd3eed265ac982c872aaf1763e0851ee415ae42adb8f45e"
    }
  }
]